Cookson Peirce & Co’s Boston Scientific BSX Stock Holding History

Cookson Peirce & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-141,817	Closed	-$13.5M	–	310
2025 Q4	$13.5M	Sell	141,817 -128,160	-47%	-$12.6M	0.56%	51
2025 Q3	$26.4M	Buy	269,977 +7,334	+3%	+$760K	1.08%	32
2025 Q2	$28.2M	Sell	262,643 -373	-0.1%	-$37.7K	1.24%	30
2025 Q1	$26.5M	Buy	263,016 +3,998	+2%	+$403K	1.33%	27
2024 Q4	$23.1M	Buy	259,018 +1,813	+0.7%	+$160K	1.05%	32
2024 Q3	$21.6M	Buy	257,205 +4,116	+2%	+$324K	1.01%	33
2024 Q2	$19.5M	Buy	253,089 +1,192	+0.5%	+$87.2K	0.94%	38
2024 Q1	$17.3M	Sell	251,897 -566	-0.2%	-$36.4K	0.92%	37
2023 Q4	$14.6M	Buy	252,463 +10,551	+4%	+$563K	0.88%	39
2023 Q3	$12.8M	Buy	241,912 +47,312	+24%	+$2.48M	0.84%	43
2023 Q2	$10.5M	Buy	194,600 +160,377	+469%	+$8.38M	0.64%	48
2023 Q1	$1.71M	Buy	+34,223	New	+$1.61M	0.11%	81

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cookson Peirce & Co's BSX Position: Q1 2026 in Review

Cookson Peirce & Co sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 141,817 shares — an estimated $13.5M sold.

Cookson Peirce & Co first reported a position in BSX in Q1 2023 and held it in 12 quarters. The position peaked at $28.2M in Q2 2025. 1,679 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cookson Peirce & Co reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Cookson Peirce & Co sold 141,817 Boston Scientific shares in Q1 2026, an estimated $13.5M.
Cookson Peirce & Co first reported a position in Boston Scientific in Q1 2023 and held it in 12 quarters.
Cookson Peirce & Co's Boston Scientific position peaked at $28.2M in Q2 2025.
1,679 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cookson Peirce & Co's 13F filing for Q1 2026, filed 30 Apr 2026.